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Abstract
We previously established a clonal porcine intramuscular preadipocyte (PIP) line and we
were able to establish a protocol to obtain functional mature adipocytes from PIP cells. We hy-
pothesized that both PIP cells and mature adipocytes are likely to be useful in vitro tools for in-
creasing our understanding of immunobiology of adipose tissue, and for the selection and
study of immunoregulatory probiotics (immunobiotics) able to modulate adipocytes immune
responses. In this study, we investigated the immunobiology of PIP cells and mature adipo-
cytes in relation to their response to TNF-α stimulation. In addition, we evaluated the possibili-
ty that immunobiotic microorganismsmodify adipogenesis and immune functions of porcine
adipose tissue through Peyer’s patches (PPs) immune-competent cells. We treated the por-
cine PPs immune cells with different probiotic strains; and we evaluated the effect of condi-
tionedmedia from probiotic-stimulated immune cells in PIP cells and mature adipocytes. The
LactobacillusGG and L. gasseri TMC0356 showed remarkable effects, and were able to sig-
nificantly reduce the expression of pro-inflammatory factors and negative regulators (A20,
Bcl-3, and MKP-1) in adipocytes challenged with TNF-α. The results of this study demonstrat-
ed that the evaluation of IL-6, and MCP-1 production, and A20 and Bcl-3 down-regulation in
TNF-α-challenged adipocytes could function as biomarkers to screen and select potential
immunobiotic strains. Taking into consideration that several in vivo and in vitro studies clearly
demonstrated the beneficial effects of LactobacillusGG and L. gasseri TMC0356 in adipose
inflammation, the results presented in this work indicate that the PIP cells and porcine adipo-
cytes could be used for the screening and the selection of new immunobiotic strains with the
potential to functionally modulate adipose inflammation when orally administered.
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Introduction
The incidence of obesity has risen continuously over the last decades, and the associated medi-
cal and economic costs to society are substantial. Obesity is often accompanied with metabolic
syndromes and increased risk for development of various life threatening health complications
such as inflammation, type 2 diabetes, cardiovascular diseases, hypercholesterolaemia, cancer,
hypertension, and respiratory problems [1–3]. Adipose tissue inflammation is proposed as a
central factor connecting obesity with its metabolic and vascular complications. In fact, obesi-
ty-induced inflammation exerts profound effects on metabolic pathways, playing one of the
central roles in the development of insulin resistance [4, 5].
Adipose tissue is considered as a major storage compartment for lipid accumulation in
mammals. This tissue is not homogenous, it contains various cellular components such as pre-
adipocytes, mature adipocytes, fibroblasts, macrophages and endothelial cells; capable of differ-
entiate into other cell types; being mature adipocytes the dominant cell type [6, 7].
Preadipocytes are able to proliferate and differentiate into lipid-laden or insulin responsive ma-
ture adipocyte, determining the number of fat cells that will exist throughout the entire lifespan
[7]. Adipose tissue is constituted by remarkable active endocrine cells that secrets a number of
adipokines: adiponectins, leptin, visfatin, resistin, serum amyloid A3, omentin and RBP4, and
inflammatory cytokines: tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1, IL-10, mono-
cyte chemoattractant protein (MCP)-1 and interferon (IFN)-γ. Those factors play pivotal roles
in the regulation of various physiological and pathological processes in which adipose tissue is
involved [6, 8].
TNF-α is a multifactorial regulatory cytokine, which has been implicated as mediator in in-
duction of insulin resistance and adipose tissue inflammation [9–11]. This cytokine is elevated
in the adipose tissues of obese mice and humans [10]. TNF-α is believed to regulate adipocyte
metabolism and immune activities by modulating glucose and fatty acid metabolism, inflam-
matory genes expression, transcriptional regulation and hormone receptor signaling [8, 9].
Studies reported that administration of TNF-α increased the glucose homeostasis and insulin
resistance in animals and humans [12, 13]. Moreover, some reports described that deletion or
lacking of TNF-α gene allowed the protection against the development of insulin resistance in
obese mice [14]. Some human studies demonstrated that treatment of obese subjects with
TNF-α antagonists is able to beneficially modulate glucose metabolism and inflammation [15,
16]. Then, regulation of TNF-α signaling pathway in adipocytes could be one strategy to con-
trol undesirable metabolic and immune effects of obesity.
Healthy food and life style habits have been recommended to avoid obesity-associated dis-
eases. Thus, finding natural and safe dietary supplements able to modulate adipocytes function
in general, and TNF-α signaling pathway in particular, would be of value to prevent obesity as-
sociated diseases. Probiotics are one of the functionally proved effective and safe dietary sup-
plements to restrain body obesity and insulin resistance. Some scientific in vivo studies
reported that probiotics supplementation reduced high fat diet induced obesity, decreased in-
sulin resistance, and beneficially modulated inflammatory response in rodent models [17, 18].
High-fat diet induced obese mice treated with Lactobacillus rhamnosus GG improved insulin
sensitivity and reduced lipid accumulation. Those effects were associated to reductions of glu-
cose transporter (GLUT4) expression and secretion of adiponectin [17]. Recently, it was re-
ported that the administration of L. coryniformis CECT5711 to obese mice induced marked
changes in microbiota composition, reduced the metabolic endotoxaemia as it decreased lipo-
polysaccharide (LPS) and TNF-α plasma levels, and improved endothelial dysfunction and
vascular oxidative stress [18].
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In a previous work, we demonstrated that the murine macrophage-like cell line J774.1 treat-
ed with L. rhamnosus GG or L. gasseri TMC0356 improved the production of IL-6 and IL-12
[19]. The conditioned medium from lactobacilli-cultured J774.1 cells transferred to the preadi-
pocyte cell line 3T3-L1 significantly suppressed lipid accumulation and decreased peroxisome
proliferator activated receptor γ (PPAR-γ) [19]. Similarly, Park et al. [20] showed that exposure
of 3T3-L1 adipocytes to L. brevisOPK-3 inhibited intracellular lipid accumulation by decreas-
ing PPAR-γ and CCAAT/enhancer binding protein α. Development of established preadipo-
cyte cell lines, such as 3T3-L1, greatly facilitated the study of molecular mechanisms of
adipocyte differentiation and inflammatory response under defined conditions. These cell lines
are derived from mouse, and preadipocyte cell lines of other species have not yet been main-
tained in culture long enough to study differentiation or immune responses. Some porcine pre-
adipocytes cell lines have been developed which maintain a normal phenotype without
transforming spontaneously even after long-term maintenance in culture [21, 22]. In this re-
gard, we have established a clonal porcine intramuscular preadipocyte (PIP) line from theMus-
culus longissimus thoractis of a Duroc pig. Moreover, we used this cell line for the investigation
of adipogenic differentiation and we were able to establish a protocol to obtain functional ma-
ture adipocytes from PIP cells [21]. Both PIP cells and mature adipocytes are likely to be useful
in vitro tools for increasing our understanding of adipogenesis and immunobiology of
adipose tissue.
In this study, we investigated the immunobiology of PIP cells and mature adipocytes in rela-
tion to their response to TNF-α stimulation. In addition, we investigated the possibility of
immunoregulatory probiotics that modify adipogenesis and immune functions of porcine adi-
pose tissue through Peyer´s patches (PPs) immune-competent cells. We treated the porcine
PPs immune cells with different immunobiotic strains [23]; and we evaluated the effect of con-
ditioned media from immunobiotic-stimulated immune cells in porcine preadipocytes (PIP
cells) and mature adipocytes.
Materials and Methods
Cell culture and induction of adipogenesis
Porcine intramuscular preadipocyte (PIP) cells, which are derived from marbling muscle tissue
of themusculus longissimus thoracis from female Duroc pig [21], were maintained in Dulbec-
co’s modified Eagle medium (DMEM, Gibco, Paisley, Scotland, UK) supplemented with 10%
fetal calf serum (FCS), 100 mg/ml penicillin, and 100 U/ml streptomycin as a growth medium.
PIP cells were plated at density of 2.5×104/cm2 in 6-well cell culture plates (BD Falcon, Tokyo,
Japan) and incubated at 37°C in a humidified atmosphere of 5% CO2. The 4-day post-conflu-
ent PIP cells were fed with differentiation medium for another 4 more days to induce differen-
tiated adipocyte. The differentiation medium was DMEM containing 10% FBS, 50 ng/ml
insulin (swine, Sigma), 0.25 μMdexamethasone (Sigma), 2 mM octanoate (Wako), 200 μM ole-
ate (Ardorich, Milwaukee, WI, USA), 100 U/ml penicillin, and 100 μg/ml streptomycin. The
medium was changed every day. All experiments were performed between the 26th and 35th
passages of PIP cells.
Oil red O and hematoxylin stain
Accumulation of intracellular lipid droplets in PIP cells and differentiated adipocytes were
quantified after staining with Oil red O. Cells were washed twice with phosphate-buffered sa-
line (PBS) and fixed on ice with 10% formaline for 30 minutes, and then cells were dissolved in
isopropanol for 1 minute and stained with Oil red O (SIGMA-ALDRICH, Tokyo, Japan) for
30 minute at 37°C. Thereafter, cells were washed twice with deionized water (DW) and stained
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with Mayer's Hematoxylin Solution (MERCK, Darmstadt, Germany). The stained cells were
then washed with DW and immersed in aqueous ammonia. Then, the cells were dried to ob-
serve and photograph lipid droplet accumulation under the biological microscope (OLYMPUS
IX70). Photographs of cells were also imaged using Image J (National Institutes of Health, Be-
thesda, MD) and measured Oil red O stained area and evaluated area per cell.
Quantitative Real-time Polymerase Chain Reaction (RT-PCR)
The expression of pattern recognition receptors (PRRs), cytokines and chemokines (IL-1α, IL-
1β, IL-6, IL-8 andMCP-1) and negative regulators (MKP-1, A20 and Bcl-3) in both PIP and dif-
ferentiated adipocyte were evaluated by RT-PCR under non-inflammatory conditions and after
the challenge with different concentration of TNF-α (2.5, 25, 250 ng/ml) for 24 h. Total RNA
was isolated from each cell sample using TRIzol reagent (Invitrogen) and cDNAs were synthe-
sized using a Quantitect reverse transcription (RT) kit (Qiagen, Tokyo, Japan) according to the
manufacturer’s recommendations. Real-time quantitative PCR was carried out using a 7300 real-
time PCR system (Applied Biosystems, Warrington, UK) and the Platinum SYBR green qPCR
SuperMix uracil-DNA glycosylase with 6-carboxyl-X-rhodamine (Invitrogen). The primer se-
quences for TNF receptors are as follows: TNFR1 (sense 5’-GGTCCATTTGCTGCACGAA-3’,
antisense 5’-GGGCCCAGACAGTCATTGTG-3’), TNFR2, (sense 5’- GCTCCACGAGGGACA
CAGA-3’, antisense 5’- AAGGGACCTGCTCATCTTTGG-3’), Nod1 (Sense 5’-CTGTCGTCAA
CACCGATCCA-3’), antisense 5’-CCAGTTGGTGACGCAGCTT-3, and Nod2 (sense 5’-GA
GCGCATCCTCTTAACTTTCG-3’, antisense 5’- ACGCTCGTGATCCGTGAAC-3’). The
primers used for the analysis of PRRs, cytokines, chemokines and TLR negative regulators were
described previously [24, 25]. The PCR cycling conditions were 5 minutes at 50°C, followed by 5
minutes at 95°C, and then 40 cycles of 15 seconds at 95°C, 30 seconds at 60°C, and 30 seconds at
72°C. The volume of reaction mixtures was 10 μl, which contains 2.5 μl of cDNA and 7.5 μl of
master mix included the sense and antisense primers. Expression of β-actin in each sample was
assessed, and the β-actin data was used as an internal control to normalize differences between
samples and to calculate relative expression levels.
Preparation of lactic acid bacterial (LAB) strains
Lactobacillus gasseri TMC0356, L. rhamnosus GG, L. rhamnosus LA-2, L. paracasei TMC0409,
Streptococcus thermophilus TMC1543, Bifidobacterium bifidum TMC3108, and B. bifidum
TMC3115 were used in this study, which were kindly gifted by Takanashi milk product compa-
ny, Japan. The lactobacilli and bifidobacterial strains were grown in deMan-Rogosa-Sharp
(MRS, Difco, Detroit, MI, USA) medium for 16 hours at 37°C. S. thermophilus were cultured in
Elliker medium (Difco) at 37°C for 16 hours. All these bacterial strains were washed with PBS
and sterilized by heating at 60°C for 30 minutes. After washing twice with PBS, the cells resus-
pended in DMEM (10% FCS, 1% streptomycin/penicillin) and adjusted cell concentration with
2.5×109 cells/ml.
Immunomodulatory activity of LAB in PIP cells and differentiated
adipocytes
For the evaluation of anti-inflammatory and anti-adipogenic activity of LAB strains, we performed
several in vitro steps to simulate LAB-immune cells-adipocytes interaction. For this purpose, we
first stimulated mononuclear cells isolated from porcine Peyer’s patches with the different LAB
strains. The immunocompetent cells isolated from porcine Peyer’s patches according to our
previous method [26] were placed in a 6-well cell culture plate (BD Falcon, 1 x 106 cells/well).
Then the cells were stimulated with LAB (5 x 107 cells /well) at 5% CO2, 37°C, for 24 hours, in a
Adipogenic and Anti-Inflammatory Activities of Immunobiotics
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complete RPMI 1640 medium (Sigma) supplemented with 2% fetal bovine serum (FCS). After
stimulation, cell free supernatant (CFS) was collected for further experiments. Both PIP and dif-
ferentiated adipocyte were pre-stimulated for 48 hours with CFS. Then, cells were post-stimulat-
ed with TNF-α for 3, 6, and 12 hours at 37°C, 5% CO2. Accumulation of intracellular lipid
droplets were quantified after staining with Oil red O. In addition, the expression of immune re-
ceptors, cytokines and negative regulators was quantified by RT-PCR.
Statistical Analysis
Analysis of variance (One-way ANOVA) was performed by GLM procedure of SAS programs
(Version 9.1). The mean comparisons between the PIP cells and adipocyte copy numbers, and
mean comparisons among the values of relative indices, and the normalized fold expressions
were carried out using tukey-kramer’s method. Relative indices were calculated as the ratio of
fat deposition in adipocyte cells; and the values are normalized by common logarithmic trans-
formation and confirmed as approximate values included significantly into normal distribu-
tion. Then, they were adjusted similarly to the mean of control groups. The mRNA expression
in the stimulated time showed as the ratio of cytokine expressions induced by TNF-α, which
was normalized by common logarithmic transformation.
Results
Immune characterization of PIP cells and differentiated adipocytes
We first aimed to morphologically characterize PIP cells and differentiated porcine adipocytes.
Fresh cells as well as cells stained with Oil red O were observed. As shown in Fig. 1, remarkable
differences were observed between PIP cells and adipocytes. PIP cells were found to be small
cells with a clear nucleus at the center surrounded by abundant cytoplasm. On the contrary,
differentiated adipocytes were observed as bigger cells than PIP cells and showed lipid droplets
that pushed nucleus to the periphery.
In addition, expression of various PRRs (TLR1–9, NOD-1 and 2) and TNFR-1 and 2 were
analyzed in PIP cells and differentiated adipocytes (Fig. 2). Both PIP cells and adipocytes ex-
pressed TLR1–9, NOD-1, NOD-2, TNFR-1 and TNFR-2. However, TNFR-1 and TNFR-2 were
highly expressed when compared with other receptors in both PIP cells and differentiated adi-
pocytes. We also observed that PIP cells showed a higher expression of NOD-1 and TLR3
when compared with adipocytes (Fig. 2). No significant differences were observed in the ex-
pression of TLR1, TLR5, TLR7–9 and NOD-2; while the expression of TLR2, TLR4, TLR6,
TNFR-1 and TNFR-2 was higher in adipocytes than in PIP cells (Fig. 2).
Response of PIP cells and adipocytes to TNF-α stimulation
We next aimed to evaluate the effect of TNF-α in the induction of inflammatory cytokines by
PIP cells and adipocytes. Fig. 3 shows the expression of cytokines in PIP and adipocyte cells.
The expressions of all cytokines were significantly up-regulated when cells were stimulated
with TNF-α. For all the pro-inflammatory cytokines and chemokines studied, the maximum
expression was observed with concentration of 25 ng/ml of TNF-α. In addition, significant dif-
ferences in the expressions of cytokines were observed between PIP cells and adipocytes. IL-1β,
and IL-8 mRNA levels were significantly higher in PIP cells than in adipocytes after TNF-α
stimulation. On the contrary, IL-1α and MCP-1 expressions were higher in adipocytes than in
PIP cells (Fig. 3). In particular, the MCP-1 expression was highest in this assay. We also evalu-
ated the effect of TNF-α in the expressions of the negative regulators MKP-1, A20 and Bcl-3 in
both PIP cells and differentiated adipocytes (Fig. 4). Challenge of PIP cells with TNF-α
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significantly increased the expression of A20 and Bcl-3 while no effect was observed in the ex-
pression of MKP-1. Similarly, stimulation of differentiated adipocytes with TNF-α increased
the expression of A20 and Bcl-3 reaching levels that were significantly higher than those ob-
served in PIP cells (Fig. 4). Moreover, TNF-α increased mRNA levels of MKP-1 in differentiat-
ed adipocytes. As observed with cytokines, for negative regulators, higher levels of expression
were also observed with 25 ng/ml of TNF-α. Therefore, this concentration of TNF-α was select-
ed for further experiments.
Evaluation of anti-inflammatory and anti-adipogenic activity of LAB
strains
For the evaluation of the anti-adipogenic and immunoregulatory activity of LAB, we per-
formed several in vitro steps to simulate LAB-immune cells-adipocytes interaction as described
in materials and methods. Then, PIP cells and adipocytes were stimulated with CFS from por-
cine Peyer’s patche immunocompetent cell cultures stimulated with different LAB strains. PIP
Fig 1. Photographic pictures of PIP and adipocyte cells. The PIP cells were grown at 37°C for 4 days, and subsequently fed with differentiation medium
for another 4 days to differentiate into adipocyte cells. Before and after adipocyte differentiation, the cells were stained with Oil red O stain. Presence of red
and blue color indicates accumulation of lipid droplets and nucleus in the adipocyte cells at 8 day.
doi:10.1371/journal.pone.0119644.g001
Adipogenic and Anti-Inflammatory Activities of Immunobiotics
PLOS ONE | DOI:10.1371/journal.pone.0119644 March 19, 2015 6 / 20
cells and adipocytes were pre-stimulated with the different CFS for 48 hours and then chal-
lenged with TNF-α for 3, 6, and 12 hours. The effect of LAB on PIP cells differentiation and
adipogenesis was investigated by using Oil red O staining (Fig. 5). The deposition of fats in the
mature adipocytes was quantified by image J. Deposition of lipids increased with differentia-
tion of PIP cells into mature adipocytes, and fat deposit were significantly increased after stim-
ulation with TNF-α (Fig. 5). In mature adipocytes coming from PIP cells treated with culture
free supernatants from LA-2 and TMC0409 strains, significantly lower deposition of lipids was
observed when compared to control cells (Fig. 5).
In addition, the mRNA levels of TLR2, TLR4, IL-6, MCP-1, and TGF-β were determined in
PIP cells and adipocytes as shown in Fig. 6. As mentioned earlier, TNF-α was capable to induce
mRNA expressions of IL-6, MCP-1, TLR2 and TLR4 in both PIP cells and differentiated adipo-
cytes (Fig. 3), while no modification was observed in the expression of TGF-β (data not
shown). A strain dependent effect was observed in the levels of IL-6, MCP-1, and TGF-β when
PIP cells were pretreated with cell free supernatants. PIP cells pretreated with cell free superna-
tant from L. rhamnosus GG, L. paracasei TMC0409 or B. bifidum TMC3108 showed increased
expression of TGF-β earlier at hour 6 post-TNF-α challenge, while those cells showed reduced
levels of IL-6 and MCP-1 at hour 12 (Fig. 6). L. rhamnosus LA-2 was able to significantly
Fig 2. Expression of pattern of PPRs (TLR1–9, NOD 1, 2) and TNFR1, 2 in PIP, and differentiated adipocyte cells.Copy number of mRNA in 25 ng of
cDNA prepared from PIP and adipocyte cells were calculated. Three independent experiments were conducted for each case and the average values
(mean ± S.D) were represented. The presence of stars (*) indicates statistical differences with significant levels of p<0.05.
doi:10.1371/journal.pone.0119644.g002
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Fig 3. TNF-α induced inflammatory cytokines in PIP and differentiated adipocyte cells. Both PIP cells and adipocytes were incubated with different
concentrations of TNF-α (2.5, 25, 250 ng/ml) for 24 hours and the level of pro-inflammatory cytokines (IL-1α, IL-1β, IL-6, IL-8, and MCP-1) were determined.
Cells without addition of TNF-α were used as controls. Three independent experiments were conducted for each case and the average values (mean ± S.D)
were represented as inflammatory effect of TNF-α. The presence of various stars (*, ** and ***) indicates statistical differences with significant levels of
p<0.05, p<0.01 and p<0.001, respectively.
doi:10.1371/journal.pone.0119644.g003
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reduce levels of IL-6 and MCP-1 but did not induce changes in TGF-β expression (Fig. 6). L.
gasseri TMC0356 significantly increased MCP-1. In addition, S. thermophilus TMC1543 re-
duced IL-6 levels but increased the expression of MCP-1; while B. bifidum TMC3115 reduced
IL-6 and MCP-1 levels (Fig. 6). Interestingly, almost all the studied LAB strains induced similar
effects in differentiated adipocytes after TNF-α challenge. L. gasseri TMC0356, L. rhamnosus
GG, L. paracasei TMC0409, S. thermophilus TMC1543 and B. bifidum TMC3108 significantly
reduced levels of IL-6, MCP-1, and TGF-β in TNF-α-challenged porcine adipocytes (Fig. 6).
On the contrary, L. rhamnosus LA-2 significantly increased levels of TGF-β in adipocytes.
Strain dependent effects were also observed when analyzing TLR2 and TLR4 expressions in
PIP cells and adipocytes pretreated with cell free supernatants (Fig. 7). L. gasseri TMC0356, S.
thermophilus TMC1543 and B. bifidum TMC3108 significantly increased TLR2 expression in
PIP cells, while L. rhamnosus GG augmented mRNA levels of TLR4. In addition, L. gasseri
TMC0356 and L. rhamnosus GG reduced TLR2 levels in differentiated adipocytes while no
Fig 4. Expression of negative regulators in PIP and differentiated adipocyte cells. Both PIP cells and adipocytes were challenged with different
concentrations of TNF-α (2.5, 25, and 250 ng/ml) for 24 hours and the level of negative regulators (MKP-1, A20, and Bcl-3) were determined. Cells without
TNF-α stimulation were used as controls. Three independent experiments were conducted for each case and the average values (mean ± S.D) were
represented as inflammatory effect of TNF-α. The presence of various stars (*, ** and ***) indicates statistical differences with significant levels of p<0.05,
p<0.01 and p<0.001, respectively.
doi:10.1371/journal.pone.0119644.g004
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significant changes were observed in the expression of TLR4 in these cells with CFS treatments
(Fig. 7).
Finally we aimed to evaluate whether CFS was able to modulate the expressions of negative
regulators after TNF-α challenge in porcine adipocytes (Fig. 8). Again, strain dependent effects
were observed. L. gasseri TMC0356 and L. rhamnosus GG significantly reduced the expression
Fig 5. Anti-adipogenic activity of various LABs. The PIP and differentiated adipocytes were incubated with CFS of various LABs treated with PPs at 37°C
for 48 hours. Mature adipocyte cells were Oil red O stained and deposition of lipid droplets in the mature adipocytes was quantified by image J. (A) Oil red O
stained mature adipocytes. (B) Photograph of image J with lipid accumulation. (C) Anti-adipogenic activity of LABs. Three independent experiments were
conducted for each case and the average values (mean ± S.D) were represented as anti-adipogenic effect of LABs. The presence of stars (*) indicates
statistical differences with significant levels of p<0.05.
doi:10.1371/journal.pone.0119644.g005
Adipogenic and Anti-Inflammatory Activities of Immunobiotics
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Fig 6. Anti-inflammatory activity of various LABs in PIP cells and differentiated adipocytes. Both PIP cells and differentiated adipocytes were pre-
stimulated with CFS of various LABs for 48 h and then post-stimulated with TNF-α for 3, 6, and 12 hours. Cells without any TNF-α stimulation were used as
cell controls. The expressions of IL-6, MCP-1, and TGF-βmRNAs were evaluated. Cells treated only with TNF-α were used as TNF-α controls. Three or four
independent experiments were conducted for each case and the average values (mean ± S.D) were represented as immunomodulatory effect of LABs. The
presence of stars (*) indicates statistical differences with significant levels of P<0.05.
doi:10.1371/journal.pone.0119644.g006
Adipogenic and Anti-Inflammatory Activities of Immunobiotics
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of A20 and Bcl-3; S. thermophilus TMC1543 and B. bifidum TMC3108 reduced levels of Bcl-3
and; B. bifidum TMC3115 reduced Bcl-3 and MKP-1 (Fig. 8). On the contrary, L. rhamnosus
LA-2 significantly increased levels of A20 and MKP-1 in adipocytes while L. paracasei
TMC0409 increased A20 and Bcl-3.
Discussion
From the histological point of view, adipose tissue is composed of adipocytes (mature fat cells)
and the interadipocytar stromal-vascular fraction formed by extracellular matrix with dis-
persed fibroblasts, preadipocytes, endothelial, and immune cells [27]. Excessive growth of adi-
pose tissue in obesity is the result from enlargement of existing adipocytes (hypertrophy) and
formation of new adipocytes (hyperplasia) through differentiation of stromal preadipocytes
(adipogenesis) [28]. Mature adipocytes represent 50–85% of the total cellular components of
adipose tissue. Obese subjects are characterized by a higher total adipocyte number than lean
individuals [29]. Moreover, the hypertrophic adipocytes in obese individuals shift their im-
mune balance towards the production of pro-inflammatory molecules [30, 31]. Accordingly,
Fig 7. Induction of TLRs expression in PIP cells and differentiated adipocytes. Both PIP cells and differentiated adipocytes were pre-stimulated with
CFS of various LABs for 48 h and then post-stimulated with TNF-α for 3, 6, and 12 hours. The expressions of TLR2 and TLR4 were evaluated. Cells treated
only with TNF-αwere used as TNF-α controls. Three or four independent experiments were conducted for each case and the average values (mean ± S.D)
were represented as immunomodulatory effect of LABs. The presence of stars (*) indicates statistical differences with significant levels of P<0.05.
doi:10.1371/journal.pone.0119644.g007
Adipogenic and Anti-Inflammatory Activities of Immunobiotics
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Fig 8. Expression of negative regulators in differentiated adipocytes. PIP cells and differentiated adipocytes were pre-stimulated with CFS of various
LABs for 48 h and then post-stimulated with TNF-α for 3, 6, and 12 hours. The expressions of A20, Bcl-3, and MKP-1 were evaluated. Cells treated only with
TNF-αwere used as TNF-α control. Three or four independent experiments were conducted for each case and the average values (mean ± S.D) were
represented as regulatory effect of LABs. The presence of stars (*) indicates statistical differences with significant levels of p<0.05.
doi:10.1371/journal.pone.0119644.g008
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microarray profiling of isolated adipocytes from obese versus non-obese Pima Indians revealed
an increased expression of inflammation-related genes in obese adipocytes [32].
In this work, the expression profile of immune receptors and pro-inflammatory cytokines
were examined in porcine preadipocytes (PIP cells) and differentiated adipocytes. TLRs that
are usually expressed immune cells, but their expression has been also documented in non-im-
mune cells like intestinal epithelial cells [23, 24, 26]. The expression of TLRs was also observed
in adipose tissue [33], although this expression was mainly attributed to infiltrated macro-
phages [34]. However, murine derived preadipocyte and differentiated adipocyte cell lines
(3T3-L1) have been shown to express TLRs in response to TLR ligands [33, 35]. Khazen et al.
[36] reported an augmented expression of TLRs when 3T3-F442A cells were differentiated into
adipocytes. TLRs are also expressed and are functional in human adipose tissue [37]. That
work demonstrated that TLR2 and TLR4 were expressed at relatively high levels (compared to
a monocyte cell line) on the surface of human adipose cells. Moreover, stimulation of human
adipocytes with LPS, or with lipoteichoic acid, two specific ligands of TLR4 and TLR2, respec-
tively, induced a strong increase in TNF-α production. Our results are in line with these previ-
ous observations since mRNAs from TLR1 to TLR9 were detected in both porcine adipose
cells. Some preliminary experiments with TLRs agonists showed that these receptors are func-
tional in porcine adipocytes, however further experiments are needed to fully evaluate TLRs
signaling pathways in PIP cells and mature adipocytes.
Our work also demonstrated the expression of TNF-α receptors (TNFR-1 and TNFR-2) in
both PIP cells and mature porcine adipocytes. Since the first description of enhanced expres-
sion and secretion of TNF-α by adipose tissue of obese rodents that linked inflammation to
obesity and insulin resistance [38], several works have clearly demonstrated that TNF-α has a
crucial role in the pathogenesis of inflammation and insulin resistance by promoting immune
and metabolic complications. It is known that most effects of TNF-α on adipose tissue are me-
diated by the TNFR-1 and subsequent activation of various transduction pathways [11]. Two
transcription factor-signaling pathways have been linked to the pro-inflammatory effects of
obesity and insulin resistance: the NF-κB (nuclear factor-κB) pathway and the c-Jun NH2-ter-
minal kinase (JNK) pathway. It is believed that overproduction of TNF-α in obesity is an ulti-
mate attempt to control adiposity, since increased TNF-αmay help at limiting further weight
gain through lipolysis and insulin resistance, impaired preadipocyte differentiation and in-
creased adipocyte apoptosis [39]. However, these effects of TNF-α occur at the expense of
worsening insulin resistance and inflammation. TNF-α produced by adipocytes further up-reg-
ulate pro-inflammatory adipokines and cytokines [40, 41]. Culturing human adipocytes in
media previously conditioned by TNF-α resulted in pro-inflammatory adipokine overproduc-
tion. This was abrogated by immunoneutralization of TNF-α in these media, indicating that
TNF-α is a crucial and proximal contributor to adipokine dysregulation in adipocytes [40]. Ac-
tivation of TNFR-1 pathway in adipocytes increases the production of other inflammatory fac-
tors such as IL-6 and MCP-1. The in vivo release of IL-6 by whole-body adipose tissue could
contribute to 15–35% of the systemic IL-6 in human and circulating levels and adipocytes pro-
duction of IL-6 are increased in obesity [42]. Infiltration of adipose tissue by macrophages is an
important event in the increased inflammatory process in obesity. MCP-1 and its receptor
(CCR2) are required for macrophage infiltration into adipose tissue. MCP-1-or CCR2-defi-
cient mice fed a high-fat diet exhibited fewer macrophages and a lower inflammatory gene pro-
file in adipose tissue together with reduced insulin resistance [43]. Treatment of 3T3-L1
differentiated adipocytes with MCP-1 decreased insulin-stimulated glucose uptake and the ex-
pression of several adipogenic genes [44]. Also, they report that the capacity of TNF-α to in-
crease pro-inflammatory factors in adipose cells. Similarly, both PIP cells and mature
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adipocytes showed significant up-regulation in the expressions of MCP-1, IL-1α, IL-1β, IL-6,
and IL-8.
Additionally, stimulation of porcine mature adipocytes with TNF-α significantly changed
the expression of negative regulators of the TNFR-1 pathway. The zinc-finger protein A20 is a
key player in the negative feedback regulation of the NF-κB pathway in response to multiple
stimuli. It is known that TNF-α dramatically increases A20 expression in all tissues, including
adipose tissue [45]. Interestingly, it was reported that the NADPH oxidase Nox4 acts as a
switch from insulin-induced proliferation to differentiation by controlling MKP-1 expression,
which limits ERK1/2 signaling in human and mouse preadipocytes [46]. The work clearly
showed that Nox4 controls the expression of MKP-1 and thereby limits the contribution of the
proliferative Ras–Raf-ERK1/2 pathway to insulin signaling. ERK1/2 phosphorylates IRS-1 on
serine-residues and thereby prevents IRS-1 tyrosine phosphorylation. The Nox4-dependent in-
duction of MKP-1 prevents this effect and therefore promotes insulin-induced differentiation
but attenuated insulin-induced proliferation. Those works demonstrated that negative regula-
tors have important roles in the biology of adipocytes, with impacts not only in immune re-
sponses but in proliferation and differentiation as well.
The data presented in this work showed that our porcine in vitro systems (PIP cells and ma-
ture adipocytes) share all the immunological characteristics that have been attributed to these
cells in other species, especially human. Then PIP cells and the porcine mature adipocytes ob-
tained from them, could be useful laboratory tools to gain insight into the immunobiology of
adipose tissue, as well as for the screening and evaluation of potential therapies aimed to bene-
ficially modulate adipose immune response. In relation to this last assumption, we demonstrat-
ed here that our porcine in vitro systems are of value for the evaluation of immunobiotic
effects.
Recently, gut microbiota has been identified as an important modifier of systemic inflam-
matory reactions influencing remote tissues [47]. Interestingly, different gut microbiota-de-
rived products can exert both pro- and anti-inflammatory effects. It was described that
translocation of LPS and peptidoglycans from microbiota into systemic circulation leads to
metabolic endotoxemia, suggested as one of the main triggers of adipose tissue and systemic
low-grade inflammation [47, 48]. On the contrary, products of gut bacterial fermentation such
as short-chain fatty acids (SCFA) were shown to have anti-inflammatory effects and influence
energy homeostasis [49]. In addition, several works demonstrated that orally administered pro-
biotics are able to modulate tissues distant from the gut including the respiratory tract [50],
blood [51], bone marrow [52], and adipose tissue [17, 18]. These studies showed that in addi-
tion to translocated microbial products, immunobiotics are able to modulate distant tissues
through their ability to modify cytokine’s profiles [50–52].
In this work we investigated the possibility that LAB modify the response of porcine adipo-
cytes to TNF-α stimulation through host’ intestinal immune-competent cells. We treated the
porcine immune cells from Peyer’s patches with different LAB strains and, tested conditioned
media from LAB-stimulated immune cells to determine the regulatory effects on porcine prea-
dipocytes (PIP cells) and differentiated adipocytes. As it is described for other probiotics’ ef-
fects, we found strain specific effects of LAB on PIP cells and differentiated adipocytes.
The Lactobacillus GG, L. gasseri TMC0356, and L. rhmanosus LA-2 showed remarkable ef-
fects with significant reduction in the expression of pro-inflammatory cytokines and chemo-
kines in adipocytes challenged with TNF-α (Fig. 9). The strains Lactobacillus GG and L. gasseri
TMC0356 reduced the expression of TLR2, A20 and Bcl-3, while A20, MKP-1 and TGF-β were
up-regulated by L. rhmanosus LA-2 in adipocyte cells. The results of Lactobacillus GG or L. gas-
seri TMC0356 mediated down-regulation were expected since some previous publications doc-
umented the capacity of these two strains to influence adipocytes immunobiology. However, a
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mechanism behind the L. rhmanosus LA-2 mediated up-regulation was unknown. In addition,
we previously used the conditioned medium of murine macrophage-like cell line J774.1 cul-
tured with LGG or TMC0356 strains to stimulate mouse preadipocyte cell line 3T3-L1 and
found a suppressed lipid accumulation and reduced PPAR-γmRNA expression [19]. More-
over, the J774 cells treated with Lactobacillus GG or L. gasseri TMC0356 increased production
of cytokines IL-6 and IL-1, suggesting that lactobacilli may suppress differentiation of preadi-
pocytes through macrophage activation and production of Th1 cytokines. Several in vivo stud-
ies have comparatively evaluated the immunoregulatory effects of L. gasseri TMC0356 and
Lactobacillus GG. Kawase et al. [53] demonstrated that oral administration of Lactobacillus GG
or L. gasseri TMC0356 alleviate nasal allergic symptoms by suppressing the increase in nasal
vascular permeability caused by local inflammation associated with allergic rhinitis in rodents.
Moreover, in an allergic rhinitis guinea pig model, both LAB strains were able to decrease the
total numbers of leukocytes, particularly eosinophils and neutrophils from the nasal cavity la-
vage fluid, and the OVA-specific IgE concentration in the serum [54]. In vitro studies of the
immune responses of murine Peyer's patches stimulated with Lactobacillus GG or L. gasseri
TMC0356 showed the capacity of both strains to increase the production of IL-6, IL-12 and
IFN-γ by intestinal immune cells [55]. Those studies clearly indicate that both Lactobacillus
GG and L. gasseri TMC0356 are equally effective in improving Th1 response not only in the
gut by in the systemic compartment as well. Similarly, in this work, CFS from cultures of por-
cine Peyer's patches with GG or TMC0356 strains were able to functionally modulate the re-
sponse of differentiated porcine adipocytes to TNF-α challenge. Then, our data suggest that
Th1 cytokines produced by intestinal immune cells will be also capable of downregulating ex-
pression of pro-inflammatory genes in mature adipocytes (Fig. 9). In line with this assumption,
L. gasseri TMC0356 was found to be able to stimulate the respiratory immune responses in a
Fig 9. Possible immunomodulatory activity of L. rhamnosusGG, L. gasseri TMC0356, and L. rhamnosus LA-2 in both PIP cells and differentiated
adipocytes after stimulation with TNF-α.
doi:10.1371/journal.pone.0119644.g009
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diet-induced obese mouse model, indicating that this immunobiotic strain may protect host
animals from the lung immune dysfunction caused by obesity [56].
Concluding Remarks
Taking into consideration that several in vivo and in vitro studies clearly demonstrated the ben-
eficial effects of Lactobacillus GG and L. gasseri TMC0356 in adipose inflammation, the results
presented in this work indicate that the PIP cells and porcine adipocytes could be used for the
screening and the selection of new immunobiotic strains with the potential to functionally
modulate adipose inflammation when orally administered. Moreover, the results of this work
demonstrated that the regulation of IL-6, MCP-1, A20 and Bcl-3 induction in TNF-α-chal-
lenged porcine adipocytes could be certain biomarkers to screen and select potential
immunobiotic strains.
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